Zhenqi Shi

Zhenqi Shi is a Senior Principal Scientist at Genentech since April 2021 and serves as Vice Chair for ASTM International's E55.01 group. From June 2021 to June 2022, Zhenqi Shi acted as Industrial Co-chair for the IFPAC 2022. Prior experience includes a role as a Senior Research Scientist at Eli Lilly and Company (January 2011 - April 2021), where Zhenqi Shi led the development of a PAT method for Lilly's first approved product, as well as contributions at US Pharmacopeia as a Chemometrics Panel Member (January 2014 - January 2020). Zhenqi Shi also completed a postdoctoral fellowship at Bristol-Myers Squibb Company and Duquesne University (March 2009 - January 2011) and held a Ph.D. from Duquesne University (2004 - 2009) and a Master’s degree from Fudan University (2001 - 2004). The academic background was reinforced with a Bachelor of Science in Pharmaceutics from Fudan University.